Group 1 - The market regulatory authority has intensified supervision in key livelihood areas such as healthcare, pharmaceuticals, medical devices, food, and children's myopia prevention, announcing ten typical cases of illegal advertising [1][2] - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding children's eye health products, including "children's lutein" and "eye nose probiotics" [1] - Nala Zun Camel (Guangzhou) Dairy Co., Ltd. was fined 450,000 yuan for misleading claims in its advertising of "camel milk powder" related to disease prevention and treatment [1] - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention [1] Group 2 - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for advertising "986 germ life enzyme" and other products with false claims about treating serious diseases [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for misleading claims in advertisements for various health products, including "myopia astigmatism lutein eye patches" [2] - Songyuan Anorectal Hospital was fined 100,000 yuan for false claims regarding its affiliation with reputable medical institutions, affecting public trust and safety [2] Group 3 - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations by promoting a prescription drug, "Sanqi Fatty Liver Pill," inappropriately [3]

Core Viewpoint - The article highlights the increasing regulatory scrutiny on misleading advertisements in key consumer sectors such as healthcare, pharmaceuticals, medical devices, and food, particularly focusing on children's eye care and cancer treatment products. Group 1: Misleading Advertisements - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for advertising products like "children's lutein" and "eye protection lamp" with false claims about disease prevention and treatment [1] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for misleading claims in its "camel milk powder" advertisements regarding health benefits [1] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic tableware as "Jingdezhen porcelain" [1] Group 2: Health Claims in Food Products - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention and treatment [2] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting products like "986 germ life enzyme" with false health claims and misleading language [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising "nearsightedness and astigmatism eye patches" with exaggerated claims about restoring vision [2] Group 3: Real Estate and Medical Device Misleading Claims - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising regarding unplanned facilities in its real estate promotions [3] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health claims related to digestive issues [3] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations for prescription drugs [3] Group 4: Regulatory Actions - In 2025, national market regulatory authorities handled 44,521 cases of advertising violations, imposing fines totaling 252 million yuan, reinforcing consumer rights protection [4]

Group 1 - The National Market Supervision Administration of China announced typical cases of illegal advertising, with Chongqing Linhui Tai Business Information Consulting Co., Ltd. fined for misleading claims related to disease prevention and treatment in their advertisements [1] - The company promoted ordinary food products such as "986 Embryo Life Enzyme," "Aerospace Longevity Bacteria," and "North Star No. 1 Biotin Tablets" using false information, claiming benefits like "can treat cancer and heart disease" and "effective for high blood pressure" [1] - The Chongqing market regulatory authority imposed an administrative penalty of 160,000 yuan on the company in November 2025 for violations of the Advertising Law of the People's Republic of China [1]

Core Viewpoint - In 2025, the National Market Supervision Administration handled a total of 44,521 advertising violation cases, imposing fines totaling 252 million yuan, effectively strengthening consumer rights protection [1]. Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding its products, including misleading statements about health benefits and the involvement of international medical experts [1]. - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for advertising its camel milk powder with false claims related to health improvements and misleading promotional content [2]. - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic products as being from Jingdezhen [3]. - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising its organic perilla seed oil with unverified health claims [4]. - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for using exaggerated claims in its advertisements for various health products [5]. - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising products with unsubstantiated health benefits [7]. - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising related to real estate developments [8]. - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health products with false claims [9]. - Songyuan Anorectal Hospital was fined 100,000 yuan for misleading advertising regarding its medical services [10]. - Yunnan Yuyao Biological Pharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations related to prescription drugs [11]. Group 2: Regulatory Actions - In 2025, the National Market Supervision Administration launched a nationwide campaign to rectify advertising market order, focusing on key areas such as healthcare, pharmaceuticals, medical devices, food, and children's vision protection [10]. - The campaign aimed to combat misleading health claims in ordinary food advertisements, illegal live-streaming of advertisements, and false citation content [10]. - A significant number of illegal advertisements related to children's eye protection, cancer treatments, longevity products, and counterfeit medical professionals were targeted during this campaign [10].